Hematology
Conference Coverage
Novel transplant regimen improves survival in primary immunodeficiency
HOUSTON – Allo-HCT following a novel reduced-intensity conditioning regimen was largely successful in an NIH study of adults and children with...
Conference Coverage
Ultrasound method predicts liver complications in pediatric transplant
HOUSTON – Using shear wave elastography predicted disease at least 4 days before standard diagnostic criteria in most patients.
Conference Coverage
Inhibitor risk nears zero after 75 days in previously untreated hemophilia A
PRAGUE – The researchers recommended frequent inhibitor testing until 75 days.
From the Journals
Meta-analysis: IVIG bests anti-D on platelet count in pediatric ITP
But the clinical significance of this finding is unclear because of the lack of data on bleeding symptoms, according to authors of the meta-...
From the Journals
Matched transplant improves stroke risk indicator in sickle cell anemia
Matched sibling donor hematopoietic stem cell transplants reduced an indicator of stroke risk, suggesting that the intervention may improve...
Conference Coverage
Tests can identify leukemia risk in newborns with Down syndrome
SAN DIEGO – These children face high rates of disease, and new research is shedding light on the reasons why.
Conference Coverage
ALL chemotherapy looks effective in mixed phenotype leukemia
SAN DIEGO – In a retrospective cohort study, most children with mixed phenotype acute leukemia achieved MRD-negative complete response on ALL-...
From the Journals
Immediate acting inhibitors complicate hemophilia A diagnosis
Researchers recommended taking a systematic approach to testing.
From the Journals
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
The findings highlight the need to screen high-risk subgroups of cancer survivors.
News
FDA approves Nplate for pediatric ITP
Approval is for pediatric patients who’ve had ITP for at least 6 months but had no good response to corticosteroids, immunoglobulins, or...
Daily News Podcast
Telemedicine not widely used
Brain injury in sickle cell merits more attention.